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Abstract
Background: A simple sensitivity analysis technique was developed to assess the impact of misclassification
and verify observed prevalence differences between distinct populations.
Methods: The prevalence of self-reported comorbid diseases in 4,331 women with surgically-diagnosed
endometriosis was compared to published clinical and population-based prevalence estimates. Disease prevalence
misclassification was assessed by assuming over-reporting in the study sample and under-reporting in the general
(comparison) population. Over- and under-reporting by 10%, 25%, 50%, 75%, and 90% was used to create a 5×5
table for each disease. The new prevalences represented by each table cell were compared by p-values, prevalence
odds ratios, and 95% confidence intervals.
Results: Three misclassification patterns were observed: 1) differences remained significant except at high
degrees (>50%) of misclassification; 2) minimal (10%) misclassification negated any observed difference; and 3)
with some (25-50%) misclassification, the difference disappeared, and the direction of significance changed at
higher levels (>50%).
Conclusions: This sensitivity analysis enabled us to verify observed prevalence differences. This useful, simple
approach is for comparing prevalence estimates between distinct populations.
Keywords: Epidemiology; Comorbid diseases; Distinct populations
Introductıon
Establishing differences in disease prevalence between populations
is a common application of epidemiology. Disease prevalence data
may be obtained using surveys, medical record reviews, and
surveillance reporting, and thus disease may be over- or
underestimated because of unmeasured confounding, misclassification
(information bias), and selection bias. While medical researchers strive
to collect valid and minimally biased data, missing or limited
validation data can be an important obstacle in addressing the effect of
misclassification. Analytic techniques may be employed to assess the
uncertainty of study results and to correct for potential bias due to
misclassification and therefore, are useful in interpreting whether
significant differences are real. Sensitivity analysis may be used to
quantitatively evaluate the effect of misclassification.
Various sensitivity analyses techniques use basic and matrix algebra
to assess and correct for differential, non-differential, or simultaneous
misclassification of exposure and disease on epidemiologic measures
of association [1-6]. Predictive values are also used to adjust relative
risk estimates and to correct for biases resulting from misclassification
of outcome status [7,8]. In some instances, computer programs are
used to perform more extensive analyses [9]. While these established
techniques for conducting a “formal” sensitivity analysis are valuable,
there are several important reasons why these comparisons may not be
carried out. First, reliable estimates of sensitivity, specificity, and true
disease frequency are often required, but may not be available. Second,
these methods make assumptions about the data such as
misclassification of only the outcome variable, sensitivity and
specificity parameters that are the same for each comparison group, or
misclassification that is considered in isolation from other forms of
bias, such as selection bias or confounding. Third, these methods are
not standardized and may be useful only with particular study designs,
further hampering their appropriate use. Finally, the methodology is
complex, such that most public health professionals or clinicians
cannot undertake a sensitivity analysis without formal training in
epidemiology or statistics [10].
The prevalence of published self-reported physician-diagnosed
autoimmune, chronic fatigue syndrome, and fibromyalgia [11], as well
as cancer, and infectious or endocrine diseases [12] in up to 4,331
women with surgically diagnosed endometriosis were compared to
prevalences from studies published in the last 30 years. Comparing
population prevalences obtained from clinical, population-based, or
self-reported studies to those that are solely self-reported may present
disparity not only due to differences in study methodology, but also
inherent differences in the populations being compared. We assumed
that women with endometriosis who self-report a diagnosis may
believe they have a disease when they actually do not, therefore biasing
prevalence estimates upward. Some diseases were rare and others, like
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infectious diseases were more commonly reported, but are less specific
and, perhaps, open to interpretation. In both instances, this may lead
to overestimation of diagnoses.
By contrast, population disease prevalence estimates based on
clinical or population-based studies may use more stringent
definitions, which might bias prevalence estimates downward. These
types of biases may result in conclusions of 1) a difference when one
does not exist (Type I error), 2) no difference when there is one (Type
II error), or 3) a difference in the opposite direction from the true
difference. We therefore considered the degree of underestimation and
overestimation of true disease prevalence because even modest
amounts of error can profoundly affect results [13].
We developed a novel sensitivity analysis approach to determine the
threshold of misclassification that would eliminate the observed
differences between the disease prevalence, in two different
populations, in this instance, for women with endometriosis and the
general female population. This provided us with a visual and
quantitative validation of the increased prevalence of comorbid
diseases among women with endometriosis. Our method only requires
a numerator and denominator for prevalence computation and does
not rely on detailed information, assumptions, or complex
methodology. Our goal was not to replace formal sensitivity analysis
techniques, which should be carried out, when possible, but to offer a
simple way to assess the impact of misclassification, and to verify study
findings.
Materials and Methods
Prevalence estimates from up to 4,331 female members of the
Endometriosis Association (International Headquarters, Milwaukee,
Wisconsin) who reported surgical diagnosis of endometriosis and the
physician diagnosis of comorbid diseases were compared to the
general population [11,12]. Exemptions from Investigational Review
Board reviews were granted by the Office of Human Subjects Research
at the National Institutes of Health, Bethesda, Maryland, and the
Committee on Human Research, The George Washington University,
Washington, DC.
Disease prevalence in the general female population for systemic
lupus erythematosus, Sjögren’s syndrome, rheumatoid arthritis,
multiple sclerosis, Hashimoto’s thyroiditis/hypothyroidism, Graves’
disease/hyperthyroidism, diabetes mellitus, chronic fatigue syndrome,
and fibromyalgia were estimated from studies published between 1969
and 2001. Age-specific population estimates of breast cancer, ovarian
cancer, non-Hodgkin’s lymphoma, and melanoma were obtained from
the National Cancer Institute’s Surveillance, Epidemiology, and End
Results (SEER) database. The remaining population prevalence
estimates were obtained from published literature or sources such as
the Centers for Disease Control and Prevention (CDC) and the
National Center for Health Statistics (NCHS). Studies were included if
prevalence could be calculated for women by 1) providing the total
number in the population for the denominator and 2) prevalence data
for women. For some, denominators were determined using U.S.
Census Bureau data. The published studies were pooled to derive
disease prevalence using standardized medical definitions, patient
interviews, clinical and laboratory evaluation, and self-reported
surveillance data. Disease prevalences for women with endometriosis
compared to the general female population prevalence estimates are
presented in Table 1.
Prevalence per 1,000
Disease Women with endometriosis Women in the general
population
Prevalence
Odds Ratio
95% Confidence Interval
Autoimmune Inflammatory Diseases
Systemic Lupus Erythematosus 8.42 0.41 20.7c 14.3, 29.9
Multiple Sclerosis 5.16 0.73 7.1c 4.4, 11.3
Rheumatoid Arthritis 18.48 12.48 1.5c 1.2, 1.9
Sjögren’s Syndrome 6.25 0.26 23.9c 15.5, 36.5
Cancers
Melanoma 6.70 1.76 3.81c 2.60, 5.56
Breasta 3.69 6.82 0.54d 0.32, 0.90
Ovary 2.31 0.67 3.43c 1.74, 6.54
Non-Hodgkin’s lymphoma 0.46 0.55 0.84 0.14, 3.37
Endocrine Diseases
Diabetes Mellitus 15.22 13.50 1.1 0.9, 1.5
Hashimoto’s thyroiditis/
Hypothyroidism
96.20 14.59 7.2c 6.4, 8.0
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Graves’ Disease/
Hyperthyroidism
17.12 19.74 0.9 0.7, 1.1
Addison’s Diseaseb 2.31 0.09 --- ---
Cushing’s Syndromeb 0.92 0.00 --- ---
Chronic Pain and Fatigue States
Fibromyalgia 58.97 34.00 1.8c 1.6, 2.1
Chronic Fatigue Syndrome 46.20 0.26 180.5c 147.2, 242.0
Infectious Diseases
Recurrent upper respiratory
Infections
351.65 70.14 7.19c 6.73, 7.68
Candidiasis 376.51 374.88 1.01 0.87, 1.16
Recurrent vaginal infections 292.54 100.00 3.72c 3.48, 3.98
History of mononucleosis 137.61 900.00 0.02c ---
Other Diseases
Mitral Valve prolapse 184.36 76.19 2.74c 2.32, 3.24
Congenital Birth Defects 27.25 30.00 0.91 0.75, 1.09
Table 1: Prevalence odds ratios of diseases among women with endometriosis and women in the general U.S. population.
a=note lower risk in women with endometriosis; b the prevalence in
the general population was extremely low for meaningful POR and
95% CI calculations; c=p<0.001; d=p<0.01
For each disease found to be statistically significantly different in
either direction, we propose selecting an appropriate range of under-
and overestimation degrees to create an n by n table for comparing the
prevalences of each disease (Appendix). In our study, we considered
the prevalence from published studies to be underestimated by 10%,
25%, 50%, 75%, and 90% and our study population prevalence
overestimated by 10%, 25%, 50%, 75%, and 90%, to create a 5 by 5
table.
The new general population and endometriosis prevalence
generated by each cell in the table were then compared by Z-tests, and
p-values were reported. To assess the magnitude of the differences and
determine the direction of the effect, prevalence odds ratios (POR) and
95% confidence intervals (CI) were calculated. A p-value of less than
or equal to 0.05, and a CI excluding 1.0 were considered statistically
significant. These results were used to identify the threshold (a “line”
connecting the cells), where statistically significant differences between
the two groups reversed. The amount of misclassification required for
results to change was subjectively defined as the midpoint along the
threshold in the table. Generally, a low degree of misclassification was
considered to be less than 50%, while misclassification greater than
50% was considered to be high.
Results
Table 2 displays the degree of overestimation in the study
population of women with endometriosis and underestimation in the
published studies that was necessary to negate the differences between
the observed disease prevalence. For most diseases that had
significantly different prevalences between the study sample and
general population, a high degree (>50% in either direction) of
misclassification was needed to eliminate these differences. However,
for some diseases, a smaller degree of misclassification nullified the
differences in prevalence between populations.
Overestimation
In Study Sample (%)
Underestimation
in the General Population
(%)
Chronic Fatigue Syndrome > 90 > 90
Breast Cancerc >90 > 90
Sjögren’s Syndrome >75 > 90
Systemic Lupus Erythematosus >75 > 90
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Multiple Sclerosis >50 > 50
Recurrent upper respiratory infections >50 > 50
Hashimoto’s thyroiditis/ hypothyroidism 75 50
Recurrent vaginal infections 50 50
Melanoma >25 >75
Mitral Valve Prolapse 25 50
Ovarian Cancer 25 50
Fibromyalgia 25 25
Rheumatoid Arthritis a a
Diabetes Mellitus b b
Graves’ Disease/ hyperthyroidism b b
Addison’s Disease b b
Cushing’s Syndrome b b
Candidiasis b b
Congenital Birth Defects b b
Table 2: Misclassification threshold for eliminating the observed statistically significant heightened risk of diseases among women with
endometriosis.
a=statistically non-significant at first level of misclassification
b=not applicable because statistically non-significant at observed
crude level, or comparison with the general population could not be
done
c=Breast cancer was observed to be statistically significantly lower
in women with endometriosis
Overall, three different patterns were observed in the 5 by 5 tables
used for our sensitivity analysis. Figure 1a represents an example of the
general pattern for those diseases that reached non-significant levels
with increasing degrees of misclassification, or those that never
reached non-significant levels. Such a pattern was noted for chronic
fatigue syndrome, breast cancer, Sjögren’s syndrome, systemic lupus
erythematosus, multiple sclerosis, and ovarian cancer, although the
threshold varied for each disease. In the second scenario (Figure 1b),
non-significant levels were reached with the lowest degree (10%) of
misclassification, and the direction of significance was reversed at
higher levels (>50%) of misclassification. This pattern was noted for
rheumatoid arthritis only. In the third pattern (Figure 1c), statistical
significance disappeared at a high level of misclassification, and then at
even higher levels (e.g., 90% overestimation and >50%
underestimation) the direction of significance was reversed. Recurrent
upper respiratory infections, Hashimoto’s thyroiditis/hypothyroidism,
recurrent vaginal infections, melanoma, mitral valve prolapse, and
fibromyalgia displayed such a pattern.
Figure 1a: Example of the first pattern: significant to non-
significant or always significant.
Figure 1b: Example of the second pattern: non-significant to
significant in reverse direction.
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Figure 1c: Example of the third pattern: significant to non-
significant to significant in reverse direction
Discussion
This novel sensitivity analysis was a technique to help assess the
impact of misclassification in disease prevalence, assuming it existed,
and verified the observed significant differences between populations.
The resulting 5 by 5 tables pictorially illustrated the analysis results
and aided in the determination of the misclassification threshold
where statistical difference between the two groups disappeared.
We observed three patterns. In the first pattern, the difference
became non-significant with high degrees (>50% in either direction) of
misclassification, suggesting the observed difference was truly
significant. Thus, higher thresholds provided a greater likelihood that
the observed differences were valid and real. In the second pattern, the
difference disappeared with the first degree (10% in either direction) of
misclassification, resulting in the failure to verify the observed
association, and suggesting that there is no association. This occurred
for only one disease, rheumatoid arthritis, in which the magnitude of
the difference was weak at the observed level. The third pattern, in
which differences disappeared and the direction of significance was
reversed at higher degrees of under- and overestimation (>50% in
either direction), leads to the opposite conclusion and suggests no
observed difference.
The interpretation of any of these patterns, the last pattern in
particular, depend on the assumed degree of misclassification based on
the study design, methodology, source of data, and other differences in
the populations that were compared. Furthermore, prevalences from
published studies need not always be considered to be underestimated
or should population prevalences always be considered to be
overestimated. These should be adjusted to what is believed to be true,
depending on the diseases in question as well as the sources from
which prevalences are being compared.
There is an increasing need for epidemiologic and biostatistical
methodology, or “how to” papers, that can be easily applied by public-
sector epidemiologists, other public health practitioners, and clinicians
[10,14]. Most methods employ complex methodology and require
detailed data, making their application by medical researchers
impractical. The method presented here is simple, yet powerful in
allowing investigators to judge their conclusions of any observed
differences against how likely they are to be true. In the absence of the
necessary information for conducting a formal analysis, we developed
this new sensitivity analysis approach. Its advantage lies in its ease of
use by any public health professional, and provides substantial power
for validating findings.
In conclusion, we developed a novel, practical sensitivity analysis
approach to verify findings by determining the degree of
misclassification necessary to negate the difference between
population prevalence estimates. The tables for each disease pictorially
illustrated three different patterns, which helped to interpret the
observed differences and sensitivity analysis results. The sensitivity
analysis presented here is a useful alternative to a formal correction
method for comparing population prevalence estimates between
different populations and could be added to routine study
methodology.
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